An Overview on ERAP Roles in Infectious Diseases

Area of Science:

• Immunology
• Biochemistry
• Molecular Biology

Background:

• Endoplasmic reticulum aminopeptidases (ERAP1 and ERAP2) are key enzymes that process peptides for presentation by Major Histocompatibility Complex class I (MHC I) molecules.
• These enzymes trim N-terminal residues from precursor peptides, generating optimal-length antigens essential for binding to the MHC I groove.
• Dysfunctional ERAPs alter the MHC I immunopeptidome, impacting Natural Killer (NK) and CD8+ T cell activation and immune surveillance.

Purpose of the Study:

• To review the role of ERAP variants in infectious disease susceptibility, development, and progression.
• To explore how ERAP function impacts the immune response to various pathogens.
• To identify potential therapeutic strategies targeting ERAP mechanisms for infectious diseases.

Main Methods:

• Literature review of studies investigating ERAP function in infectious diseases.
• Analysis of experimental evidence linking ERAP deficiency or variation to altered immune responses.
• Examination of the mechanisms by which ERAPs influence antigen presentation and immune cell activation.

Main Results:

• ERAP1-deficient mice exhibit impaired control of Toxoplasma gondii infection, highlighting the role of ERAPs in host defense.
• Studies demonstrate that ERAPs act as critical control factors for a range of infectious organisms.
• Alterations in ERAP function significantly affect the repertoire of pathogen-derived antigens presented by MHC I, influencing disease outcomes.

Conclusions:

• ERAP variants play a significant role in modulating susceptibility and progression of infectious diseases.
• Understanding ERAP function in antigen processing is crucial for comprehending immune responses to pathogens.
• Targeting ERAP mechanisms presents a promising avenue for developing novel therapeutic approaches against infectious diseases.